
P4A Let's Talk Rare: The Life Science Podcast
Solving Patient Matching in Rare Disease Trials
<p>One of the most persistent barriers in rare disease drug development isn’t the science — it’s identifying and reaching the small number of patients who could benefit from emerging therapies.</p><p>Without solving this, even the most promising innovations risk never reaching the people who need them most.</p><p>In our latest podcast episode, we explore how the industry can better connect patients to clinical trials — and why this is critical to accelerating progress in rare disease.</p><p>We’re delighted to welcome Dr Jennifer Levin, CEO of Medzown, who shares how her team is working to...

